Mostrando 8 resultados de: 8
Filtros aplicados
Publisher
CNS Neuroscience and Therapeutics(1)
Current Neurovascular Research(1)
Current Pharmaceutical Design(1)
Journal of Alzheimer's Disease(1)
Journal of Pineal Research(1)
Área temáticas
Enfermedades(7)
Fisiología humana(6)
Farmacología y terapéutica(3)
Bioquímica(1)
Fisiología y materias afines(1)
Origen
scopus(8)
An evaluation of the neuroprotective effects of melatonin in an in vitro experimental model of age-induced neuronal apoptosis
ArticleAbstract: The neuroprotective effects of melatonin in an experimental model of aging-induced apoptosis have bePalabras claves:aging, cell cycle, Neurodegeneration, P53Autores:Antoni Camins, Pallás M., Pelegrí Gabalda C., Tajes Orduña M., Vilaplana J.Fuentes:scopusAntiapoptotic drugs: A therapautic strategy for the prevention of neurodegenerative diseases
ReviewAbstract: The purpose of this review is to discuss potential pathways involved in the pathogenesis of neurodegPalabras claves:Alzheimer's disease, apoptosis, Cyclin-dependent kinases, Glutamate receptors, Neuronal cell death, Neuroprotective drugs. apoptosis, Parkinson's DiseaseAutores:Antoni Camins, Auladell C., Canudas A.M., Folch J., Junyent F., Pallás M., Pelegrí Gabalda C., Sureda F.X., Verdaguer E., Vilaplana J., Zárate C.B.Fuentes:scopusGSK3β inhibition is involved in the neuroprotective effects of cyclin-dependent kinase inhibitors in neurons
ArticleAbstract: In the present study, we evaluated the effects of roscovitine (Rosco) and flavopiridol (Flavo), bothPalabras claves:apoptosis, Cerebellar granular cells, flavopiridol, GSK3β, RoscovitineAutores:Antoni Camins, Auladell C., de la Torre A.V., Folch J., Junyent F., Pallás M., Pelegrí Gabalda C., Verdaguer E., Vilaplana J., Zárate C.B.Fuentes:scopusEarly amyloid accumulation in the hippocampus of SAMP8 mice
ArticleAbstract: Late-onset Alzheimer's disease (AD) is the most common form of AD appearing after 65 years of age. TPalabras claves:aging, Alzheimer's disease, Amyloid-β, Aβ40, Aβ42, AβPP, hippocampus, SAMP8, SAMR1, SenescenceAutores:Antoni Camins, Casadesús G., Del Valle J., Duran-Vilaregut J., Manich G., Pallás M., Pelegrí Gabalda C., Smith M.A., Vilaplana J.Fuentes:scopusIncreased permeability of blood-brain barrier on the hippocampus of a murine model of senescence
ArticleAbstract: SAMP8 mice show several indicative characteristics of accelerated aging and have been used to studyPalabras claves:blood-brain barrier, Confocal microscopy, hippocampus, IgG quantification, Immunohistochemistry, mouse, SAMP8, SenescenceAutores:Antoni Camins, Canudas A.M., Casadesús G., Del Valle J., Pallás M., Pelegrí Gabalda C., Smith M.A., Vilaplana J.Fuentes:scopusResveratrol and neurodegenerative diseases: Activation of SIRT1 as the potential pathway towards neuroprotection
ReviewAbstract: One of the current problems in medicine research is the development of safe drugs for the treatmentPalabras claves:Autores:Antoni Camins, Casadesús G., Coto-Montes A., Pallás M., Pelegrí Gabalda C., Smith M.A., Vilaplana J.Fuentes:scopusPotential mechanisms involved in the prevention of neurodegenerative diseases by lithium
ReviewAbstract: Lithium is a monovalent cation that was introduced in 1949 by John Cade for the treatment of bipolarPalabras claves:Alzheimer disease, Autophagy, GSK-3β, Lithium, Oxidative Stress, Parkinson DiseaseAutores:Antoni Camins, Junyent F., Pallás M., Pelegrí Gabalda C., Verdaguer E., Vilaplana J., Yeste-Velasco M.Fuentes:scopusSystemic administration of 3-nitropropionic acid points out a different role for active caspase-3 in neurons and astrocytes
ArticleAbstract: The intraperitoneal administration of 3-nitropropionic acid, which is commonly used to induce toxiciPalabras claves:apoptosis, Huntington's disease, Neurodegeneration, RAT, Striatum, TUNELAutores:Antoni Camins, Del Valle J., Duran-Vilaregut J., Junyent F., Manich G., Pallás M., Pelegrí Gabalda C., Vilaplana J.Fuentes:scopus